Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2551 AL 2565

Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation

Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Johnson J, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF.

Neurobiol Aging. 2012 Aug;33(8):1843.e9-17. doi: 10.1016/j.neurobiolaging.2011.12.036. Epub 2012 Feb 1.

[Review in geriatric medicine 2011]

Rochat S, Doser N, Eyer S, Jabri A, Rubli E, Büla C.

Rev Med Suisse. 2012 Jan 11;8(323):23-7.

Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison

Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative.

J Nucl Med. 2012 Apr;53(4):592-600. doi: 10.2967/jnumed.111.094946. Epub 2012 Feb 17.

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease

Rissman RA, Trojanowski JQ, Shaw LM, Aisen PS.

J Neural Transm (Vienna). 2012 Jul;119(7):843-50. doi: 10.1007/s00702-012-0772-4. Epub 2012 Feb 22.

Family history and APOE-4 genetic risk in Alzheimer's disease

Donix M, Small GW, Bookheimer SY.

Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23.

Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing

Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2012;30(2):323-36. doi: 10.3233/JAD-2012-120058.

[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]

Kovacs J, Pakaski M, Juhasz A, Feher A, Drotos G, Fazekas CO, Horvath TL, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Mar;14(1):19-27.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.

Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.

Rapidly progressive Alzheimer's disease: a multicenter update

Schmidt C, Haïk S, Satoh K, Rábano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I.

J Alzheimers Dis. 2012;30(4):751-6. doi: 10.3233/JAD-2012-120007.

Relevance of in vivo neurophysiological biomarkers for mild cognitive impairment and Alzheimer's disease

Yamasaki T, Horie S, Muranaka H, Kaseda Y, Mimori Y, Tobimatsu S.

J Alzheimers Dis. 2012;31 Suppl 3:S137-54. doi: 10.3233/JAD-2012-112093.

Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients

Albani D, Martinelli Boneschi F, Biella G, Giacalone G, Lupoli S, Clerici F, Benussi L, Ghidoni R, Galimberti D, Squitti R, Mariani S, Confaloni A, Bruno G, Mariani C, Scarpini E, Binetti G, Magnani G, Franceschi M, Forloni G.

J Alzheimers Dis. 2012;30(4):745-9. doi: 10.3233/JAD-2012-112123.

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E; AAB-001 201/202 Investigators.

Arch Neurol. 2012 Aug;69(8):1002-10. doi: 10.1001/archneurol.2012.90.

Brain imaging in Alzheimer disease

Johnson KA, Fox NC, Sperling RA, Klunk WE.

Cold Spring Harb Perspect Med. 2012 Apr;2(4):a006213. doi: 10.1101/cshperspect.a006213.

Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies

Ventriglia M, Bucossi S, Panetta V, Squitti R.

J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias